McIlrath & Eck’s CME Group CME Stock Holding History

McIlrath & Eck’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-50	Closed	-$9K	–	893
2022 Q3	$9K	Buy	+50	New	+$9.88K	﹤0.01%	545
2020 Q2	–	Sell	-26	Closed	-$4K	–	666
2020 Q1	$4K	Buy	+26	New	+$5.17K	﹤0.01%	463

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

McIlrath & Eck's CME Position: Q4 2022 in Review

McIlrath & Eck sold out of CME Group (CME) in Q4 2022, closing a stake of 50 shares — an estimated $9K sold.

McIlrath & Eck first reported a position in CME in Q1 2020 and held it in 2 quarters. The position peaked at $9K in Q3 2022. 1,149 funds tracked by Wall St. Rank hold CME as of Q4 2022.

McIlrath & Eck reported no remaining CME Group position as of Q4 2022 after selling out during the quarter.
McIlrath & Eck sold 50 CME Group shares in Q4 2022, an estimated $9K.
McIlrath & Eck first reported a position in CME Group in Q1 2020 and held it in 2 quarters.
McIlrath & Eck's CME Group position peaked at $9K in Q3 2022.
1,149 funds tracked by Wall St. Rank held CME Group as of Q4 2022.

Based on McIlrath & Eck's 13F filing for Q4 2022, filed 15 Feb 2023.